Fredric Regenstein

2.4k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Fredric Regenstein is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Fredric Regenstein has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 22 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Fredric Regenstein's work include Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (13 papers). Fredric Regenstein is often cited by papers focused on Hepatitis C virus research (21 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (13 papers). Fredric Regenstein collaborates with scholars based in United States, Russia and Italy. Fredric Regenstein's co-authors include Robert P. Perrillo, Stanford T. Roodman, Lizhe Xu, Andrew L. Mason, Clive Wasserfall, Johnson Y.N. Lau, Graeme J.M. Alexander, Keping Qian, James E. Everhart and Linsheng Guo and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and Hepatology.

In The Last Decade

Fredric Regenstein

31 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection

1999 523 citations Andrew L. Mason, Johnson Y.N. Lau et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fredric Regenstein United States	16	1.1k	1.0k	130	117	100	33	1.3k
Hugo Fainboim Argentina	22	1.2k 1.1×	1.1k 1.1×	123 0.9×	199 1.7×	46 0.5×	54	1.4k
G Teuber Germany	25	1.5k 1.4×	1.3k 1.3×	103 0.8×	204 1.7×	23 0.2×	108	1.7k
M Duffaut France	16	971 0.9×	827 0.8×	97 0.7×	108 0.9×	14 0.1×	49	1.2k
Nyingi Kemmer United States	20	791 0.7×	649 0.6×	390 3.0×	121 1.0×	74 0.7×	65	1.1k
U Palazzo Italy	16	1.1k 1.0×	925 0.9×	311 2.4×	42 0.4×	66 0.7×	32	1.3k
Montserrat Garcı́a-Retortillo Spain	17	1.6k 1.5×	1.4k 1.4×	204 1.6×	73 0.6×	24 0.2×	52	1.7k
G. Bellati Italy	23	1.2k 1.1×	1.0k 1.0×	271 2.1×	64 0.5×	14 0.1×	49	1.4k
Marie–Pierre Ripault France	20	2.2k 2.1×	2.2k 2.2×	91 0.7×	131 1.1×	87 0.9×	34	2.5k
J.F. Sánchez-Ávila Mexico	15	802 0.8×	794 0.8×	142 1.1×	68 0.6×	70 0.7×	50	1.0k
Mario Rizzetto Italy	19	775 0.7×	795 0.8×	424 3.3×	83 0.7×	18 0.2×	80	1.3k

Countries citing papers authored by Fredric Regenstein

Since Specialization

Citations

This map shows the geographic impact of Fredric Regenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredric Regenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredric Regenstein more than expected).

Fields of papers citing papers by Fredric Regenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredric Regenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredric Regenstein. The network helps show where Fredric Regenstein may publish in the future.

Co-authorship network of co-authors of Fredric Regenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Fredric Regenstein. A scholar is included among the top collaborators of Fredric Regenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredric Regenstein. Fredric Regenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Regenstein, Fredric, et al.. (2021). Light Chain Deposition Disease: An Unusual Cause of Portal Hypertension. Hepatology. 74(6). 3546–3548. 3 indexed citations

Weinberg, Ethan M., Michael P. Curry, Catherine Frenette, et al.. (2020). Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis. Liver Transplantation. 27(4). 568–579. 14 indexed citations

Regenstein, Fredric, et al.. (2017). Hepatosplenic T-Cell Lymphoma in Patient With Crohnʼs Disease Receiving Immunomodulator Therapy: A Case Report. The American Journal of Gastroenterology. 112. S1215–S1216.

Regenstein, Fredric, et al.. (2010). M1026 Predicting Survival Following Liver Transplant Using Artificial Neural Networks: Optimizing the Unos Database Using Machine Learning Techniques. Gastroenterology. 138(5). S–824. 1 indexed citations

Coffin, Carla S., Peter G. Stock, Lorna Dove, et al.. (2010). HBV and HIV Coinfection and Liver Transplant. American Journal of Transplantation. 10(5). 1268–1275. 69 indexed citations

Ghalib, Reem, Risë Stribling, Terry Box, et al.. (2003). Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2b plus ribavirin. Preliminary analysis. Gastroenterology. 124(4). A694–A694. 4 indexed citations

Ahmed, Furqaan, Ira M. Jacobson, Robert S. Brown, et al.. (2003). Clinical significance of pegylated interferon induced neutropenia: Results from the WIN-R trial. Gastroenterology. 124(4). A700–A700. 5 indexed citations

Regenstein, Fredric, et al.. (2002). Variceal hemorrhage. Current Treatment Options in Gastroenterology. 5(1). 73–80. 11 indexed citations

Gaglio, Paul J., et al.. (2000). alpha-1 antitrypsin deficiency and splenic artery aneurysm rupture: an association?. The American Journal of Gastroenterology. 95(6). 1531–1534. 15 indexed citations

10.

Mason, Andrew L., Johnson Y.N. Lau, Keping Qian, et al.. (1999). Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection. Hepatology. 29(2). 328–333. 523 indexed citations breakdown →

11.

Simon, Douglas, S. Gordon, Marshall M. Kaplan, et al.. (1997). Treatment of Chronic Hepatitis C With Interferon Alfa–N3: A Multicenter, Randomized, Open–Label Trial. Hepatology. 25(2). 445–448. 15 indexed citations

12.

Jones, Elizabeth C., et al.. (1997). Comparison of Quantitative HCV RNA Assays in Chronic Hepatitis C. American Journal of Clinical Pathology. 107(3). 362–367. 17 indexed citations

13.

Lee, David H., Hassan H. Jamal, Fredric Regenstein, & Robert P. Perrillo. (1997). Morbidity of Chronic Hepatitis C as Seen in a Tertiary Care Medical Center. Digestive Diseases and Sciences. 42(1). 186–191. 86 indexed citations

14.

Perrillo, Robert, Carlo H. Tamburro, Fredric Regenstein, et al.. (1995). Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology. 109(3). 908–916. 132 indexed citations

15.

Regenstein, Fredric. (1994). New approaches to the treatment of chronic viral hepatitis B and C. The American Journal of Medicine. 96(1). S47–S51. 21 indexed citations

16.

Balart, Luis A., Robert Perrillo, Fredric Regenstein, et al.. (1993). Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology. 104(5). 1472–1477. 56 indexed citations

17.

Shieh, Yi‐Shing, Pietro Lampertico, Lennox J. Jeffers, et al.. (1991). Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction.. PubMed. 65(4). 408–11. 27 indexed citations

18.

Perrillo, Robert P., et al.. (1985). Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology. 88(3). 780–786. 72 indexed citations

19.

Regenstein, Fredric, et al.. (1985). Clinical and immunologic features of chronic dialysis patients who fail to respond to hepatitis B vaccine. Vaccine. 3(1). 27–30. 9 indexed citations

20.

Regenstein, Fredric, Stanford T. Roodman, & Robert P. Perrillo. (1983). Immunoregulatory T Cell Subsets in Chronic Hepatitis B Virus Infection: The Influence of Homosexuality. Hepatology. 3(6). 951–954. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact